NASDAQ:BCYC

Bicycle Therapeutics Stock Insider Trading

etoro logo Buy BCYC
*Your capital is at risk
$4.20
-0.1000 (-2.33%)
At Close: Jun 03, 2026

Bicycle Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 65.51. In total, the insiders bought 1.96M and sold 85.81K BCYC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
65.51
Buy 1.96M shares
Sell 85.81K shares
50% Buy Activity
Strong Negative Correlation
Buy Signal Medium Confidence
Mar 17, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 65.51.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Skynner Michael
Chief Technology Officer
Officer 824
Value: $7K
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Milnes Alistair
Chief Operating Officer
C-Suite Officer 1 147
Value: $10K
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Hannay Michael Charles Ferguson
Chief Prod & Supply Chain Off
Officer 473
Value: $4K
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Young Alethia
Chief Financial Officer
C-Suite Officer 217
Value: $2K
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Young Alethia
Chief Financial Officer
C-Suite Officer 265
Value: $2K
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Thompson Travis Alvin
Chief Accounting Officer
Officer 221
Value: $2K
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Swanton Robert Charles
Director
Director 102
Value: $872
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Swanton Robert Charles
Director
Director 102
Value: $872
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Thompson Travis Alvin
Chief Accounting Officer
Officer 221
Value: $2K
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Young Alethia
Chief Financial Officer
C-Suite Officer 265
Value: $2K
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Young Alethia
Chief Financial Officer
C-Suite Officer 217
Value: $2K
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Hannay Michael Charles Ferguson
Chief Prod & Supply Chain Off
Officer 473
Value: $4K
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Milnes Alistair
Chief Operating Officer
C-Suite Officer 1 147
Value: $10K
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Skynner Michael
Chief Technology Officer
Officer 824
Value: $7K
Oct 02, 2025
Sell
Ordinary Shares
S-Sale
Lee Kevin
Chief Executive Officer
CEO / President 2 263
Value: $19.0K
Sep 08, 2025
Buy
Stock Option (right to buy)
A-Award
Hoppenot Herve
Director
Director 25 000
Value: $179.0K
Sep 08, 2025
Buy
Ordinary Shares
A-Award
Hoppenot Herve
Director
Director 12 500
Value: $87.5K
Sep 08, 2025
Buy
Stock Option (right to buy)
A-Award
Dansey Roger D
Director
Director 25 000
Value: $179.0K
Sep 08, 2025
Buy
Ordinary Shares
A-Award
Dansey Roger D
Director
Director 12 500
Value: $87.5K
Sep 08, 2025
Buy
Common Stock
J-Other
Hoppenot Herve
Insider
Other 0
Value: $0
Sep 08, 2025
Buy
Common Stock
J-Other
Dansey Roger D
Insider
Other 0
Value: $0
Sep 08, 2025
Buy
Common Stock
J-Other
Hoppenot Herve
Insider
Other 0
Value: $0
Sep 08, 2025
Buy
Ordinary Shares
A-Award
Dansey Roger D
Director
Director 12 500
Value: $87.5K
Sep 08, 2025
Buy
Stock Option (right to buy)
A-Award
Dansey Roger D
Director
Director 25 000
Value: $179.0K
Sep 08, 2025
Buy
Ordinary Shares
A-Award
Hoppenot Herve
Director
Director 12 500
Value: $87.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BICYCLE THERAPEUTICS PLC
Bicycle Therapeutics
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The company's oncology product candidates also comprise BT5528, a BTC that is in a Phase I/II clinical trial ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE